MENU
+Compare
LSTA
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$2.80
Change
-$0.14 (-4.76%)
Capitalization
24.07M

LSTA Lisata Therapeutics Forecast, Technical & Fundamental Analysis

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases... Show more

LSTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for LSTA with price predictions
Jun 27, 2025

LSTA in upward trend: price rose above 50-day moving average on June 25, 2025

LSTA moved above its 50-day moving average on June 25, 2025 date and that indicates a change from a downward trend to an upward trend. In of 40 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where LSTA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 26, 2025. You may want to consider a long position or call options on LSTA as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LSTA just turned positive on June 26, 2025. Looking at past instances where LSTA's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where LSTA advanced for three days, in of 238 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for LSTA moved out of overbought territory on June 27, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 19 similar instances where the indicator moved out of overbought territory. In of the 19 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LSTA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LSTA broke above its upper Bollinger Band on June 26, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.949) is normal, around the industry mean (16.366). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). LSTA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (23.529) is also within normal values, averaging (252.247).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LSTA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LSTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
LSTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

LSTA is expected to report earnings to rise 16.36% to -63 cents per share on August 18

Lisata Therapeutics LSTA Stock Earnings Reports
Q2'25
Est.
$-0.64
Q1'25
Beat
by $0.19
Q4'24
Beat
by $0.30
Q3'24
Beat
by $0.16
Q2'24
Beat
by $0.14
The last earnings report on May 09 showed earnings per share of -55 cents, beating the estimate of -74 cents. With 42.13K shares outstanding, the current market capitalization sits at 24.07M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
110 Allen Road
Phone
+1 908 842-0100
Employees
25
Web
https://www.lisata.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALL195.761.61
+0.83%
Allstate Corp (The)
GOLF73.320.05
+0.07%
Acushnet Holdings Corp
AKBA3.74N/A
N/A
Akebia Therapeutics
DC3.78N/A
N/A
Dakota Gold Corp
NRXS2.50-0.02
-0.79%
Neuraxis

LSTA and Stocks

Correlation & Price change

A.I.dvisor tells us that LSTA and RAIN have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LSTA and RAIN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LSTA
1D Price
Change %
LSTA100%
-4.76%
RAIN - LSTA
27%
Poorly correlated
+5.79%
GMAB - LSTA
27%
Poorly correlated
-1.11%
IMVT - LSTA
27%
Poorly correlated
-1.77%
ASND - LSTA
26%
Poorly correlated
-0.42%
TPST - LSTA
26%
Poorly correlated
-2.68%
More